A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men

[1]  Faraz Hach,et al.  Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.

[2]  Lawrence D. True,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[3]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[4]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[5]  C. Liao,et al.  Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma. , 2014, Cancer cell.

[6]  S. Srivastava,et al.  Predominance of ERG-negative high-grade prostate cancers in African American men. , 2014, Molecular and clinical oncology.

[7]  M. Rubin,et al.  Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men , 2014, Clinical Cancer Research.

[8]  Huiqing Yuan,et al.  ERG Rearrangement Is Associated with Prostate Cancer-Related Death in Chinese Prostate Cancer Patients , 2014, PloS one.

[9]  G. van der Pluijm,et al.  Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth , 2013, Oncotarget.

[10]  H. Hieronymus,et al.  SPOP mutations in prostate cancer across demographically diverse patient cohorts. , 2014, Neoplasia.

[11]  Stine H. Kresse,et al.  Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model , 2014, Molecular Cancer.

[12]  Chao-yuan Huang,et al.  Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients. , 2013, European journal of cancer.

[13]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[14]  Peilin Jia,et al.  Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers , 2013, Genome Medicine.

[15]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[16]  S. Srivastava,et al.  Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men , 2013, International journal of molecular sciences.

[17]  A. Sivachenko,et al.  Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.

[18]  V. Beneš,et al.  Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. , 2013, Cancer cell.

[19]  S. Ambs,et al.  Biological determinants of health disparities in prostate cancer , 2013, Current opinion in oncology.

[20]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[21]  S. Srivastava,et al.  Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. , 2012, Urology.

[22]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[23]  A. Sivachenko,et al.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.

[24]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.

[25]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[26]  Ken Chen,et al.  SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..

[27]  Sohrab P. Shah,et al.  JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data , 2012, Bioinform..

[28]  S. Hochreiter,et al.  cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate , 2012, Nucleic acids research.

[29]  Tatiana Popova,et al.  Supplementary Methods , 2012, Acta Neuropsychiatrica.

[30]  J. Downing,et al.  High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. , 2010, Blood.

[31]  A. Børresen-Dale,et al.  Analyzing cancer samples with SNP arrays. , 2012, Methods in molecular biology.

[32]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[33]  M. Freedman,et al.  The genetics of cancer risk. , 2011, Cancer journal.

[34]  Stephen J. Salipante,et al.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.

[35]  G. Chornokur,et al.  Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer , 2011, The Prostate.

[36]  M. Rubin,et al.  TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african‐american and japanese patients , 2011, The Prostate.

[37]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[38]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[39]  D. Berney,et al.  Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. , 2010, Cancer research.

[40]  S-H Tan,et al.  ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification , 2010, Prostate Cancer and Prostatic Diseases.

[41]  W. Sakr,et al.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. , 2010, The Journal of urology.

[42]  R. Wilson,et al.  BreakDancer: An algorithm for high resolution mapping of genomic structural variation , 2009, Nature Methods.

[43]  Stine H. Kresse,et al.  LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization , 2009, Genes, chromosomes & cancer.

[44]  Terence P. Speed,et al.  A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6 , 2009, Bioinform..

[45]  Chen Sun,et al.  Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer , 2008, Clinical Cancer Research.

[46]  V. Srikantan,et al.  Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2006, Oncogene.

[47]  Paulo A. S. Nuin,et al.  Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. , 2006, Cancer Genetics and Cytogenetics.

[48]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[49]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[50]  H. Gabra,et al.  The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates , 2005, Clinical Cancer Research.

[51]  V. Srikantan,et al.  Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2005, Oncogene.

[52]  C. Larsson,et al.  The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. , 2003, Cancer cell.

[53]  J. Serth,et al.  Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. , 2003, Oncology reports.

[54]  S. Kaminskyj,et al.  5' RACE by tailing a general template-switching oligonucleotide. , 2000, BioTechniques.

[55]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[56]  R. Harvey,et al.  Random-primed cDNA synthesis facilitates the isolation of multiple 5'-cDNA ends by RACE. , 1991, Nucleic acids research.

[57]  F. Ramaekers,et al.  Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[58]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[59]  D. Bigner,et al.  Patterns of the early, gross chromosomal changes in malignant human gliomas. , 2008, Hereditas.